Mario-Livio Jeličić

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Mass Spectrometry

Quality Control

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Daniela Amidžić Klarić, Jelena Kovačić, Mario-Livio Jeličić, Snježana Zubčić, Vladimir Stankov, Marija Gulan Čičak, Boris Bučar, Ilija Klarić, Ana Mornar
Assessment of Physicochemical Parameters and Contaminants in Herbal Dietary Supplements Used in the Treatment of Inflammatory Bowel Disease. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Daniela Amidžić Klarić, Jelena Kovačić, Mario-Livio Jeličić, Snježana Zubčić, Vladimir Stankov, Marija Gulan Čičak, Boris Bučar, Ilija Klarić, Ana Mornar
Assessment of Physicochemical Parameters and Contaminants in Herbal Dietary Supplements Used in the Treatment of Inflammatory Bowel Disease. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Mario-Livio Jeličić, Daniela Amidžić Klarić, Jelena Kovačić, Donatella Verbanac, Ana Mornar
Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
Mario-Livio Jeličić, Jelena Kovačić, Matija Cvetnić, Ana Mornar, Daniela Amidžić Klarić
Antioxidant Activity of Pharmaceuticals: Predictive QSAR Modeling for Potential Therapeutic Strategy. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Edvin Brusač, Mario-Livio Jeličić, Matija Cvetnić, Daniela Amidžić Klarić, Biljana Nigović, Ana Mornar
A Comprehensive Approach to Compatibility Testing Using Chromatographic, Thermal and Spectroscopic Techniques: Evaluation of Potential for a Monolayer Fixed-Dose Combination of 6-Mercaptopurine and Folic Acid. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Mario-Livio Jeličić, Edvin Brusač, Stanislav Kurajica, Matija Cvetnić, Daniela Amidžić Klarić, Biljana Nigović, Ana Mornar
Drug-Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools. Pharmaceutics 13 (3) (2021)